Table 5.
Correlation of RC with other potential risk factors in the T2DM-PAD patients.
| Variables | Spearman Correlation Analysis | |
|---|---|---|
| r | P value | |
| Gender | 0.330 | <0.001 |
| Age | -0.093 | 0.129 |
| Diabetes duration | -0.027 | 0.660 |
| Hypertension | -0.002 | 0.969 |
| SBP | 0.012 | 0.845 |
| DBP | 0.035 | 0.567 |
| ALT | 0.080 | 0.191 |
| Urea | 0.002 | 0.968 |
| Cr | -0.083 | 0.175 |
| eGFR | -0.019 | 0.754 |
| HDL-C | -0.111 | 0.069 |
| CRP | 0.073 | 0.229 |
| Fasting glucose | 0.125 | 0.040 |
| HbA1c (%) | 0.061 | 0.315 |
| TG | 0.614 | <0.001 |
| TC | 0.342 | <0.001 |
| HDL-C | -0.111 | 0.069 |
| LDL-C | 0.054 | 0.380 |
| N-HDL-C | 0.379 | <0.001 |
| TyG index | 0.485 | <0.001 |
| NLR | -0.051 | 0.409 |
| MLR | -0.041 | 0.500 |
| PHR | 0.123 | 0.044 |
SBP, systolic blood pressure; DBP, diastolic blood pressure; ALT, alanine aminotransferase; Cr, creatinine; eGFR, estimated glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; CRP, C-reactive protein; RC, remnant cholesterol; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; N-HDL-C, non-HDL-C; TyG index, triglyceride glucose index; NLR, neutrophil to lymphocyte ratio; MLR, monocyte to lymphocyte ratio; PHR, platelet/HDL-C ratio. P < 0.05 (two-sided) was defined as statistically significant. Bold values indicate statistically significance.